Rang	Name	Position
1	Mr. Joseph H. Capper	CEO & Director
2	Mr. Douglas C. Rice CPA	Chief Financial Officer
3	Mr. William F. Hulse IV	General Counsel & Chief Administrative Officer
4	Ms. Kimberly Maersk-Moller	Chief Commercial Officer
5	Dr. John Harper Ph.D.	SVP of R&D & Medical Affairs and Chief Scientific Officer
6	Mr. Matthew M. Notarianni	Head of Investor Relations
7	Mr. Mark P. Graves	Senior VP & Chief Compliance Officer
8	Ms. Hilary Dixon	Vice President of Investor Relations & Corporate Strategic Communications
9	Mr. Eric A. Smith	Senior VP of Marketing & International
10	Ms. Tracy Chastain	Chief Human Resources Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Essex Woodlands Health Ventures	19,04%	126,97 Mio. USD
2	BlackRock Inc	8,04%	53,64 Mio. USD
3	Trigran Investments Inc	4,84%	32,31 Mio. USD
4	Vanguard Capital Management, LLC	3,49%	23,26 Mio. USD
5	State Street Corp	3,41%	22,77 Mio. USD
6	Paradigm Capital Management, Inc.	2,75%	18,34 Mio. USD
7	Nantahala Capital Management, LLC	2,29%	15,30 Mio. USD
8	Renaissance Technologies Corp	2,04%	13,60 Mio. USD
9	Geode Capital Management, LLC	1,95%	12,98 Mio. USD
10	Punch & Associates Inv Mgmt Inc	1,39%	9,27 Mio. USD
11	Dimensional Fund Advisors, Inc.	1,31%	8,76 Mio. USD
12	Cannell Capital LLC	1,26%	8,42 Mio. USD
13	Marshall Wace Asset Management Ltd	1,26%	8,38 Mio. USD
14	Qube Research & Technologies	1,12%	7,44 Mio. USD
15	Charles Schwab Investment Management Inc	0,93%	6,21 Mio. USD
16	The Goldman Sachs Group Inc	0,80%	5,34 Mio. USD
17	Vanguard Portfolio Management, LLC	0,75%	4,98 Mio. USD
18	Meros Investment Management, LP	0,74%	4,92 Mio. USD
19	Deutsche Bank AG	0,70%	4,66 Mio. USD
20	Northern Trust Corp	0,69%	4,61 Mio. USD